Idiopathic Intracranial Hypertension

Neurologic Clinics

Volumn 28, Issue 3, 2010, Pages 593-617

  Wall, Michael ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Idiopathic intracranial hypertension; Papilledema; Pseudotumor cerebri; Visual loss

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; FUROSEMIDE; TOPIRAMATE; TOPOMAX; UNCLASSIFIED DRUG;

BLURRED VISION; CEREBROSPINAL FLUID SHUNTING; CLINICAL FEATURE; DECOMPRESSION SURGERY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EYE EDEMA; EYE EXAMINATION; EYE MOVEMENT DISORDER; FENESTRATION; HEADACHE; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; NERVE SHEATH; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTIC DISK; OPTIC NERVE; PAPILLEDEMA; PATHOGENESIS; PERIMETRY; PHLEBOGRAPHY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SINUS VENOSUS; STENT; STOMACH SURGERY; TINNITUS; TRANSIENT VISUAL OBSCURATION; VISION; VISUAL IMPAIRMENT; WEIGHT REDUCTION; BLINDNESS; COMPLICATION; FEMALE; MALE; PATHOLOGY; PROCEDURES; PSEUDOTUMOR CEREBRI; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

BLINDNESS; FEMALE; HEADACHE; HUMANS; MALE; OPTIC NERVE; PAPILLEDEMA; PERIMETRY; PSEUDOTUMOR CEREBRI; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; VISUAL FIELD TESTS;

EID: 77954699522     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2010.03.003     Document Type: Review

References (102)

1. Corbett J.J., Savino P.J., Thompson H.S., et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982, 39:461-474.
2. Wall M., Hart W.M., Burde R.M. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 1983, 96:654-669.
3. Corbett J.J., Mehta M.P. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983, 33:1386-1388.
4. Smith J.L. Whence pseudotumor cerebri?. J Clin Neuroophthalmol 1985, 5:55-56.
5. Durcan F.J., Corbett J.J., Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988, 45:875-877.
6. Radhakrishnan K., Ahlskog J.E., Cross S.A., et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993, 50:78-80.
7. Corbett J.J. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983, 10:221-229.
8. Wall M., George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991, 114:155-180.
9. Digre K.B., Corbett J.J. Pseudotumor cerebri in men. Arch Neurol 1988, 45:866-872.
10. Ireland B., Corbett J.J., Wallace R.B. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990, 47:315-320.
11. Giuseffi V., Wall M., Siegel P.Z., et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991, 41:239-244.
12. Greer M. Benign intracranial hypertension. II. Following corticosteroid therapy. Neurology 1963, 13:439-441.
13. Neville B.G., Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J 1970, 3:554-556.
14. Walsh F.B. Papilledema associated with increased intracranial pressure in Addison's disease. Arch Ophthalmol 1952, 47:86.
15. Digre K.B., Varner M.W., Corbett J.J. Pseudotumor cerebri and pregnancy. Neurology 1984, 34:721-729.
16. Deonna T., Guignard J.P. Acute intracranial hypertension after nalidixic acid administration. Arch Dis Child 1974, 49:743.
17. Mushet G.R. Pseudotumor and nitrofurantoin therapy [letter]. Arch Neurol 1977, 34:257.
18. Konomi H., Imai M., Nihei K., et al. Indomethacin causing pseudotumor cerebri in Bartter's syndrome [letter]. N Engl J Med 1978, 298:855.
19. Larizza D., Colombo A., Lorini R., et al. Ketoprofen causing pseudotumor cerebri in Bartter's syndrome [letter]. N Engl J Med 1979, 300:796.
20. Feldman M.H., Schlezinger N.S. Benign intracranial hypertension associated with hypervitaminosis A. Arch Neurol 1970, 22:1-7.
21. Spector R.H., Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 1984, 34:1509-1511.
22. Van Dop C., Conte F.A., Koch T.K., et al. Pseudotumor cerebri associated with initiation of levothyroxine therapy for juvenile hypothyroidism. N Engl J Med 1983, 308:1076-1080.
23. Saul R.F., Hamburger H.A., Selhorst J.B. Pseudotumor cerebri secondary to lithium carbonate. JAMA 1985, 253:2869-2870.
24. Shah A., Roberts T., McQueen I.N., et al. Danazol and benign intracranial hypertension. Br Med J (Clin Res Ed) 1987, 294:1323.
25. Bercaw B.L., Greer M. Transport of intrathecal 131-I risa in benign intracranial hypertension. Neurology 1970, 20:787-790.
26. Jacobson D.M., Karanjia P.N., Olson K.A., et al. Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 1990, 40:1454-1455.
27. Wall M., Dollar J.D., Sadun A.A., et al. Idiopathic intracranial hypertension: lack of histologic evidence for cerebral edema. Arch Neurol 1995, 52:141-145.
28. Mathew N.T., Meyer J.S., Ott E.O. Increased cerebral blood volume in benign intracranial hypertension. Neurology 1975, 25:646-649.
29. Brooks D.J., Beaney R.P., Leenders K.L., et al. Regional cerebral oxygen utilization, blood flow, and blood volume in benign intracranial hypertension studied by positron emission tomography. Neurology 1985, 35:1030-1034.
30. Boulton M., Armstrong D., Flessner M., et al. Raised intracranial pressure increases CSF drainage through arachnoid villi and extracranial lymphatics. Am J Physiol 1998, 275(3 Pt 2):889-896.
31. Sahs A.L., Joynt R.J. Brain swelling of unknown cause. Neurology 1956, 6:791-803.
32. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990, 10:331-335.
33. Friedman D.I., Rausch E.A. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002, 58:1551-1553.
34. Sadun A., Currie J., Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol 1984, 16:489-494.
35. Meador K.J., Swift T.R. Tinnitus from intracranial hypertension. Neurology 1984, 34:1258-1261.
36. Farb R.I., Vanek I., Scott J.N., et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003, 60:1418-1424.
37. Wall M., White W.N. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998, 39:134-142.
38. Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatr 1982, 45:13-18.
39. Scott C.J., Kardon R.H., Lee A.G., et al. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography (OCT) compared to clinical expert assessment using a Clinical Staging Scale. Arch Ophthalmol 2010, in press.
40. Cushing H. Strangulation of the nervi abducentes by lateral branches of the basilar artery in cases of brain tumor. Brain 1910, 33:204-235.
41. Wall M., George D. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy. Arch Neurol 1987, 44:170-175.
42. Corbett J.J., Jacobson D.M., Mauer R.C., et al. Enlargement of the blind spot caused by papilledema. Am J Ophthalmol 1988, 105:261-265.
43. Shah V.A., Kardon R.H., Lee A.G., et al. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience. Neurology 2008, 70:634-640.
44. Wall M. The morphology of visual field damage in idiopathic intracranial hypertension: an anatomic region analysis. Perimetry update 1990/1991 1991, 20-27. Kugler Publications, Amsterdam. R.P. Mills, A. Heijl (Eds.).
45. Hayreh S.S. Pathogenesis of optic disc oedema in raised intracranial pressure. Trans Ophthalmol Soc U K 1976, 96:404-407.
46. Hayreh S.S. The sheath of the optic nerve. Ophthalmologica 1984, 189:54-63.
47. Hayreh S.S. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977, 95:1553-1565.
48. Hayreh S.S., March W., Anderson D.R. Pathogenesis of block of rapid orthograde axonal transport by elevated intraocular pressure. Exp Eye Res 1979, 28:515-523.
49. Tso M.O., Hayreh S.S. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema. Arch Ophthalmol 1977, 95:1458-1462.
50. Neville L., Egan R.A. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol 2005, 40:775-777.
51. Whiteley W., Al Shahi R., Warlow C.P., et al. CSF opening pressure: reference interval and the effect of body mass index. Neurology 2006, 67:1690-1691.
52. Bono F., Quattrone A. CSF opening pressure: reference interval and the effect of body mass index. Neurology 2007, 68:1439-1440.
53. Bono F., Lupo M.R., Serra P., et al. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology 2002, 59:1641-1643.
54. Corbett J.J., Thompson H.S. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989, 46:1049-1051.
55. Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med 1974, 133:802-807.
56. Johnson L.N., Krohel G.B., Madsen R.W., et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998, 105:2313-2317.
57. Kupersmith M.J., Gamell L., Turbin R., et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998, 50:1094-1098.
58. Wong R., Madill S.A., Pandey P., et al. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 2007, 7:15.
59. Sugerman H.J., Felton W.L., Sismanis A., et al. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999, 229:634-640.
60. Johnston I., Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974, 97:301-312.
61. Scoffings D.J., Pickard J.D., Higgins J.N. Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatr 2007, 78:911-912.
62. McCarthy K.D., Reed D.J. The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974, 189:194-201.
63. Gücer G., Viernstein L. Long-term intracranial pressure recording in management of pseudotumor cerebri. J Neurosurg 1978, 49:256-263.
64. Tomsak R.L., Niffenegger A.S., Remler B.F. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuroophthalmol 1988, 8:93-98.
65. Celebisoy N., Gokcay F., Sirin H., et al. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007, 116:322-327.
66. Zimran A., Beutler E. Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts?. Am J Ophthalmol 1987, 104:654-658.
67. Lee A.G., Anderson R., Kardon R.H., et al. Presumed " sulfa allergy" in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality?. Am J Ophthalmol 2004, 138:114-118.
68. Shah V.A., Fung S., Shahbaz R., et al. Idiopathic intracranial hypertension. Ophthalmology 2007, 114:617.
69. Pollay M., Fullenwider C., Roberts P.A., et al. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983, 59:945-950.
70. Kessler L.A., Novelli P.M., Reigel D.H. Surgical treatment of benign intracranial hypertension-subtemporal decompression revisited. Surg Neurol 1998, 50:73-76.
71. Goh K.Y., Schatz N.J., Glaser J.S. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuroophthalmol 1997, 17:86-91.
72. Acheson J.F., Green W.T., Sanders M.D. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatr 1994, 57:1426-1429.
73. Sergott R.C., Savino P.J., Bosley T.M. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988, 106:1391-1397.
74. Corbett J.J., Nerad J.A., Tse D., et al. Optic nerve sheath fenestration for pseudotumor cerebri: the lateral orbitotomy approach. Arch Ophthalmol 1988, 106:1391-1397.
75. Plotnik J.L., Kosmorsky G.S. Operative complications of optic nerve sheath decompression [review]. Ophthalmology 1993, 100:683-690.
76. Brourman N.D., Spoor T.C., Ramocki J.M. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988, 106:1378-1383.
77. Chandrasekaran S., McCluskey P., Minassian D., et al. Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Experiment Ophthalmol 2006, 34:661-665.
78. Curry W.T., Butler W.E., Barker F.G. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005, 57(1):97-108. [discussion: 97-108].
79. Eggenberger E.R., Miller N.R., Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996, 46:1524-1530.
80. Rosenberg M., Smith C., Beck R. The efficacy of shunting procedures in pseudotumor cerebri. Neurology 1989, 39:209.
81. Burgett R.A., Purvin V.A., Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997, 49:734-739.
82. Johnston I., Besser M., Morgan M.K. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988, 69:195-202.
83. McGirt M.J., Woodworth G., Thomas G., et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004, 101(4):627-632.
84. King J.O., Mitchell P.J., Thomson K.R., et al. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002, 58:26-30.
85. Friedman D.I. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2006, 26:61-64.
86. Wall M. Papilledema and idiopathic intracranial hypertension (pseudotumor cerebri). Neurological theraputics principles and practice 2006, 1955-1968. Informa Healthcare, Abingdon (UK). 2nd edition. J.H. Noseworthy (Ed.).
87. Cinciripini G.S., Donahue S., Borchert M.S. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999, 127:178-182.
88. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992, 37:155-166.
89. Babikian P., Corbett J., Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol 1994, 9:144-149.
90. Balcer L.J., Liu G.T., Forman S., et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999, 52:870-872.
91. Bruce B.B., Kedar S., Van Stavern G.P., et al. Idiopathic intracranial hypertension in men. Neurology 2009, 72:304-309.
92. Lee A.G., Golnik K., Kardon R., et al. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002, 109:482-485.
93. Sugita Y., Iijima S., Teshima Y., et al. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol 1985, 60:214-219.
94. Jennum P., Borgesen S.E. Intracranial pressure and obstructive sleep apnea. Chest 1989, 95:279-283.
95. Lee A.G., Pless M., Falardeau J., et al. The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am J Ophthalmol 2005, 139(5):855-859.
96. Hupp S.L., Glaser J.S., Frazier-Byrne S. Optic nerve sheath decompression. Review of 17 cases. Arch Ophthalmol 1987, 105:386-389.
97. Kelman S.E., Heaps R., Wolf A., et al. Optic nerve decompression surgery improves visual function in patients with pseudotumor cerebri. Neurosurgery 1992, 30:391-395.
98. Corbett J.J., Nerad J.A., Tse D.T., et al. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol 1988, 106:1391-1397.
99. Banta J.T., Farris B.K. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 2000, 107:1907-1912.
100. Rosenberg M.L., Corbett J.J., Smith C., et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993, 43:1071-1072.
101. Shapiro S., Yee R., Brown H. Surgical management of pseudotumor cerebri in pregnancy: case report. Neurosurgery 1995, 37:829-831.
102. Bynke G., Zemack G., Bynke H., et al. Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology 2004, 63(7):1314-1316.